Dana HARB, et al. “The Off-Label Use of Rituximab for the Management of Inflammatory Disorders: American University of Beirut Medical Center Experience”. Archives of Rheumatology, vol. 29, no. 3, Sept. 2014, pp. 194-02, doi:10.5606/ArchRheumatol.2014.3855.